Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trialIvan Fan-Ngai Hung, Kwok-Yung Yuen, Tom Wai‐Hin Chung et al.|The Lancet|2020Cited by 1.6k
Disseminated Penicilliosis, Recurrent Bacteremic Nontyphoidal Salmonellosis, and Burkholderiosis Associated with Acquired Immunodeficiency Due to Autoantibody against Gamma InterferonBone Siu-Fai Tang, Kwok‐Yung Yuen, Jasper Fuk‐Woo Chan et al.|Clinical and Vaccine Immunology|2010Cited by 112